Interventions for treating intrahepatic cholestasis in people with sickle cell disease

The Cochrane Database of Systematic Reviews
Arturo J Martí-Carvajal, Daniel Simancas-Racines

Abstract

Sickle cell disease is the most common hemoglobinopathy occurring worldwide and sickle cell intrahepatic cholestasis is a complication long recognized in this population. Cholestatic liver diseases are characterized by impaired formation or excretion (or both) of bile from the liver. There is a need to assess the clinical benefits and harms of the interventions used to treat intrahepatic cholestasis in people with sickle cell disease. To assess the benefits and harms of the interventions for treating intrahepatic cholestasis in people with sickle cell disease. We searched the Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register, which comprises references identified from comprehensive electronic database searches and handsearching of relevant journals and abstract books of conference proceedings. We also searched the LILACS database (1982 to 7 July 2014) and the WHO International Clinical Trials Registry Platform Search Portal (7 July 2014).Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register: 10 October 2014. We searched for published or unpublished randomised controlled trials. Each author intended to independently extract data and a...Continue Reading

Citations

Aug 2, 2018·The Cochrane Database of Systematic Reviews·Patricia M FortinLise J Estcourt
Jun 23, 2020·The Cochrane Database of Systematic Reviews·Arturo J Martí-Carvajal, Cristina Elena Martí-Amarista
Aug 2, 2017·The Cochrane Database of Systematic Reviews·Arturo J Martí-Carvajal, Cristina Elena Martí-Amarista
Mar 19, 2019·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Romain Fort

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The Cochrane Database of Systematic Reviews
Arturo J Martí-CarvajalJennifer M Knight-Madden
The Cochrane Database of Systematic Reviews
Uduak Okomo, Martin M Meremikwu
The Cochrane Database of Systematic Reviews
Vanitha A JagannathAnne B Chang
The Cochrane Database of Systematic Reviews
Sarah H L Yi, Rani H Singh
The Cochrane Database of Systematic Reviews
Alison Morton, Susan Wolfe
© 2021 Meta ULC. All rights reserved